A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood …

DA Walker, JF Liu, M Kieran, N Jabado… - Neuro …, 2013 - academic.oup.com
Astrocytic tumors account for 42% of childhood brain tumors, arising in all anatomical
regions and associated with neurofibromatosis type 1 (NF1) in 15%. Anatomical site …

A systematic review of time to diagnosis in children and young adults with cancer

CD Lethaby, S Picton, SE Kinsey, R Phillips… - Archives of disease in …, 2013 - adc.bmj.com
Purpose It is often assumed that prolonged time to diagnosis (TTD) for cancer negatively
influences overall survival and survivorship through advanced stage disease at diagnosis …

TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity

S Thiesen, P Yin, AL Jorgensen, JE Zhang… - Pharmacogenetics …, 2017 - journals.lww.com
Objectives Cisplatin ototoxicity affects 42–88% of treated children. Catechol-O-
methyltransferase (COMT), thiopurine methyltransferase (TPMT) and AYCP2 genetic …

[HTML][HTML] Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade …

SS Bielack, S Smeland, JS Whelan… - Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
Purpose EURAMOS-1, an international randomized controlled trial, investigated
maintenance therapy with pegylated interferon alfa-2b (IFN-α-2b) in patients whose …

A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702)

T Stokland, JF Liu, JW Ironside, DW Ellison… - Neuro …, 2010 - academic.oup.com
The purpose of this study was to identify risk factors for the progression of low-grade glioma
in children from a large population-based cohort. Patient and tumor details of a national …

[PDF][PDF] Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome

M De Vos, BE Hayward, S Picton, E Sheridan… - The American Journal of …, 2004 - cell.com
We investigated a family with an autosomal recessive syndrome of café-au-lait patches and
childhood malignancy, notably supratentorial primitive neuroectodermal tumor. There was …

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

PG Kemps, J Picarsic, BH Durham… - Blood, The Journal …, 2022 - ashpublications.org
ALK-positive histiocytosis is a rare subtype of histiocytic neoplasm first described in 2008 in
3 infants with multisystemic disease involving the liver and hematopoietic system. This entity …

[HTML][HTML] A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment …

AK Gnekow, DA Walker, D Kandels, S Picton… - European journal of …, 2017 - Elsevier
Background The use of chemotherapy to manage newly diagnosed low grade glioma (LGG)
was first introduced in the 1980s. One randomised trial has studied two-versus four-drug …

Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation

S Yost, B De Wolf, S Hanks, A Zachariou, C Marcozzi… - Nature …, 2017 - nature.com
Through exome sequencing, we identified six individuals with biallelic loss-of-function
mutations in TRIP13. All six developed Wilms tumor. Constitutional mosaic aneuploidies …

Treatment of recurrent central nervous system primitive neuroectodermal tumours in children and adolescents: results of a Children's Cancer and Leukaemia Group …

B Pizer, PHJ Donachie, K Robinson, RE Taylor… - European journal of …, 2011 - Elsevier
BACKGROUND: The treatment of previously irradiated patients with recurrent central
nervous system primitive neuroectodermal tumours (PNETs) is a considerable challenge. A …